Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-08-15Clinical Trial Update: An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 1]
A Phase 1 trial evaluating NNC 0151-0000-0000 for systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-21Clinical Trial Update: Study of Epratuzumab in Systemic Lupus Erythematosus [Phase 3]
Phase 3 study of epratuzumab in systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-21Clinical Trial Update: Atacicept Demonstrating Dose RESponSe [Phase 2]
A Phase 2 trial of atacicept for systemic lupus erythematosus, which had shown dose response, was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-01Clinical Trial Update: Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) [Phase 2]
A Phase 2 clinical trial evaluating lupus immunosuppressive/immunomodulatory therapy or stem cell transplant has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-10-08Clinical Trial Update: Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE [Phase 2]
A Phase 2 trial evaluating Rituximab-induced B-cell depletion and its effects on T cells in systemic lupus erythematosus has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-04-30Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus [Phase 2]
A Phase 2 trial of R935788 for systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-03-30Clinical Trial Update: Doxycycline Outcomes in Lupus Erythematosus [Phase 4]
A Phase 4 trial evaluating doxycycline in patients with lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-11-08Clinical Trial Update: Study of Epratuzumab in Systemic Lupus Erythematosus [Phase 3]
A Phase 3 study of the monoclonal antibody epratuzumab for systemic lupus erythematosus was terminated.
-
CLINICAL_TRIALS withdrawal · 2011-04-12Clinical Trial Update: A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus [Phase 2]
The Phase 2 study evaluating tolerability, safety and effectiveness of Edratide in systemic lupus erythematosus was terminated.
-
CLINICAL_TRIALS withdrawal · 2008-05-08Clinical Trial Update: Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus [Phase 1]
Phase 1 study of TRU-015 for membranous nephropathy secondary to systemic lupus erythematosus was terminated.